Search results for "SAR"

showing 10 items of 6699 documents

Musiikkikasvatuksellinen työ suomalaisissa kirkkokunnissa ekumenian näkökulmasta

2015

Tarkastelen tutkielmassa suomalaisia kirkkokuntia ja niiden musiikkikasvatuksellisesti merkittävää työtä tänä päivänä. Tavoitteena oli saada selville, millaista musiikkitoimintaa kussakin kirkkokunnassa on ja mitkä näistä kirkoista tukevat monipuolista musiikkitoimintaa yhteislaulujen lisäksi, kuten yhtyesoittoa, kuoroja tai orkestereita. Työn avulla halusin myös selvittää, onko evankelis-luterilaisen kirkon lisäksi muilla seurakunnilla palkattuja ja koulutettuja musiikkityöntekijöitä ja jos on/ei ole, niin miksi. Musiikkityöntekijöiden koulutustausta sekä se, perustuuko toiminta palkkaukseen vai vapaaehtoisuuteen kiinnostaa musiikin ammattilaisena. Ekumenia eli kristittyjen yhteinen toimin…

musiikkityöekumeniaseurakuntakirkkomusiikkikasvatusVapaakirkkoPelastusarmeija
researchProduct

Kokonaisarkkitehtuurin rooli hankehallinnassa : case sairaanhoitopiirit

2012

Kokonaisarkkitehtuurin rooli hankehallinnassa –tutkielmassa keskitytään tar-kastelemaan julkishallinnon hankehallinnon ja muutostenhallinnon tilaa sai-raanhoitopiireissä. Kirjallisuudessa kokonaisarkkitehtuuria suositellaan käytet-täväksi organisaatioiden kokonaisuuksien hallintaan. Kokonaisarkkitehtuurilla (KA) hallittaessa organisaatiossa toimintoja se muodostuu myös yhdeksi joh-tamistavaksi. Kokonaisarkkitehtuurilla pyritään siihen, että organisaation kaik-ki olennaiset hankkeet ohjaavat organisaation toimintatapoja ja järjestelmiä or-ganisaation haluamaan suuntaan. Suunta, johon pyritään, on kirjoitettuna or-ganisaatioiden strategiaan. Hankehallinto ja muutoshallinto ovat organisaatiois…

muutoshallintohallintoorganisaatiothankehallintoKAhankkeetkokonaisarkkitehtuurimuutostenhallintamuutoksenhallintasairaanhoitopiirit
researchProduct

Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.

2009

We report seven patients with immune-mediated rippling muscle disease (iRMD) and AChR-antibody positive myasthenia gravis (MG) without germline caveolin-3 gene mutations. We describe the follow-up of two patients and the clinical features of five new patients (1 female, 4 male, aged 32 to 69 years). These presented with significant generalized, exercise-induced and electrically-silent muscle rippling with myalgia, combined with generalized MG. In two of the seven patients, MG appeared before iRMD. Mediastinal imaging excluded thymic alterations in all, although two had other coincident tumours. Myalgia and rippling were aggravated by acetylcholinesterase-inhibitor treatment. Generalized MG …

myalgiaAdultMalePathologymedicine.medical_specialtyCaveolin 3Immunogenicmedicine.medical_treatmentMuscle Fibers SkeletalMuscle ProteinsCaveolin-3; Immunogenic; Myasthenia gravis; Rippling muscle disease; TherapyAzathioprineThymus GlandGene mutationBiologyCaveolaeDysferlinCaveolin-3Muscular DiseasesAzathioprineMyasthenia GravismedicineHumansMuscle SkeletalGenetics (clinical)AgedAutoantibodiesSarcolemmaElectromyographyAutoantibodyRippling muscle diseasePlasmapheresisMiddle Agedmedicine.diseaseMyasthenia gravisNeurologyPediatrics Perinatology and Child Healthbiology.proteinPlasmapheresisFemaleSteroidsTherapyNeurology (clinical)Cholinesterase Inhibitorsmedicine.symptommedicine.drugFollow-Up StudiesMuscle ContractionNeuromuscular disorders : NMD
researchProduct

COVID‐19 in older adults: What are the differences with younger patients?

2020

Aim The present study aimed both to gain knowledge on the distinctive clinical characteristics of older adults with coronavirus disease 2019 (COVID‐19), in comparison with those of younger patients, and to identify risk factors for mortality. Methods A retrospective observational study was carried out of patients consecutively admitted to Doctor Peset University Hospital, Valencia (Spain) for COVID‐19 from 11 March to 28 April 2020. Every case was diagnosed by reverse transcription polymerase chain reaction or by serology test to detect antibodies. Demographic details, clinical characteristics, laboratory findings on admission and complications of each case were collected from electronic me…

myalgiaAdultMalemedicine.medical_specialtyAdolescentFevercoronavirusComorbiditySerology03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicine030502 gerontologyCOVID‐19Risk FactorsInternal medicinemedicineHumansHospital Mortalityclinical characteristicsolder adultsOxygen saturation (medicine)AgedRetrospective StudiesAged 80 and overCreatininebusiness.industrySARS-CoV-2Medical recordAge FactorsCOVID-19Retrospective cohort studyOdds ratioOriginal ArticlesMiddle AgedmortalityConfidence intervalHospitalizationchemistryCoughSpainORIGINAL ARTICLE: Epidemiology Clinical Practice and HealthFemalemedicine.symptom0305 other medical sciencebusiness030217 neurology & neurosurgeryGeriatrics & Gerontology International
researchProduct

Myoadenylate deaminase deficiency

1987

Myoadenylate deaminase (MAD) is the rate-limiting enzyme in the purine nucleotide cycle which is biochemically linked to glycolysis and the citric cycle and thereby providing energy during intense muscular activity. In muscle fibers, myoadenylate deaminase operates at considerably higher activity levels than in other organs. First detected using enzyme-histochemical methods, it now appears that deficiency of myoadenylate deaminase is one of the most frequent enzyme defects in muscle. The primary defect may occur as an isolated nosological entity or not infrequently it is also associated with a large spectrum of different neuromuscular conditions. It seems to be the primary unassociated MAD …

myalgiaWeaknessmedicine.medical_specialtyBiopsyElectromyographyMetabolic myopathyBiologyGastroenterologyAMP Deaminase03 medical and health sciences0302 clinical medicineInternal medicineDrug DiscoveryBiopsymedicineHumansGenetics (clinical)030304 developmental biology0303 health sciencesmedicine.diagnostic_testMusclesMuscle weaknessAMP deaminaseNeuromuscular DiseasesGeneral Medicinemedicine.diseaseEndocrinologyNucleotide DeaminasesMolecular MedicineSarcoidosismedicine.symptom030217 neurology & neurosurgeryKlinische Wochenschrift
researchProduct

A Single-Center (Sibiu, Romania), Retrospective Study (March–November 2020) of COVID-19 Clinical and Epidemiological Features in Children

2021

The aim of this study was to describe and analyze epidemiological and clinical features of children screened for COVID-19 at Sibiu Pediatric Clinical Hospital during the first 9 months (March–November) of coronavirus disease pandemic in Romania. A total of 203 pediatric patients with a confirmed diagnosis of COVID-19 were included in the study. The median age of the patients was 121 (IQR 18–181) months and 52.22% had mild clinical type with pneumonia, 35.47% were moderate cases, 3.94% severe cases, 0.99% critically ill cases and 7.39% were asymptomatic. The most common symptoms were fever (n = 130, 64.03%), nasal congestion (n = 138, 67.98%), cough (n = 128, 63.05%) followed by sore throat …

myalgiamedicine.medical_specialtyAbdominal painrhinorrheaclinical featuresbusiness.industrySARS-CoV-2coronavirusRCOVID-19General MedicineNasal congestionAsymptomaticArticlepediatricchildrenInternal medicinemedicineVomitingSore throatMedicineepidemiologyLeukocytosismedicine.symptombusinessJournal of Clinical Medicine
researchProduct

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort.

2022

Background and aims. Patients with Myasthenia gravis (MG) are considered vulnerable as they may present with respiratory muscle weakness and because they are on immunosuppressive treatment; thereby, COVID-19 may have a detrimental effect on these patients. Vaccines against COVID-19 are currently available and it has been shown as they can prevent severe COVID-19 in vulnerable patients. Notwithstanding their efficacy, vaccine hesitancy has not been completely dispelled in the general population. Unfortunately, there is limited data about the safety of these vaccines in MG patients. The aims of this study are to evaluate the impact of COVID-19 in a MG cohort, the adherence to COVID-19 vaccina…

myasthenic crisisvaccineCOVID-19; SARS-CoV2; vaccine; Myasthenia gravis; neuromuscular; myasthenic crisisSARS-CoV2COVID-19neuromuscularNeurology (clinical)Myasthenia gravisNeurology international
researchProduct

"Tie yksi ja sama, matka ei" : Pentti Saarikosken Tiarnia-sarja esteettisen politiikan näkökulmasta

2004

myytitHariman RobertTiarnia-sarjalyriikkaestetiikkaLacoue-Labarthe PhilippeSaarikoski PenttihermeneutiikkaRicœur Paullabyrintitpolitiikkamimesisesteettinen politiikkaAnkersmit F. Rtutkimus
researchProduct

Latvijas Zinātņu akadēmijas akadēmiķis Ojārs Spārītis: biobibliogrāfija

2016

Akadēmiķa O. Spārīša biobibliogrāfija ietver viņa publikācijas un rakstus par viņu no 1966.g. līdz 2015.g. decembrim. Biobibliogrāfiju ievada O. Spārīša domubiedru, kolēģu veltījuma sveicieni. To noslēdz personu rādītājs.

mākslas vēsturepieminekļu aizsardzībakultūrvēsturebiobibliogrāfijazinātne - Latvija
researchProduct

Evaluation of radiological findings with COVID-19 lung lesions in Latvia in the view of artificial intelligence and radiologist

2022

Pēc Pasaules Veselības organizācijas datiem kopš pandēmijas sākuma kopējais ar Covid-19 saslimušo cilvēku skaits pārsniedz 500 miljonus. Mākslīgais intelekts (MI) paver plašas iespējas Covid-19 infekcijas izraisīto plaušu bojājumu diagnostikā, kas var uzlabot un atvieglojot radiologa darbu veicinot gan izmeklējuma specifitātes, gan sensitivitātes izvērtēšanas iespējas. Šī pētījuma galvenais mērķis bija salīdzināt MI un radiologa atradnes precizitāti Covid-19 radītā plaušu bojājuma izvērtēšanā un noteikt interpretācijas ierobežojumus un priekšrocības klīniskā kontekstā. Savukārt darba uzdevumi bija iepazīties un apkopot datus ar jaunāko literatūru par MI pielietošanas iespējām medicīnā. Apko…

mākslīgais intelekts artificial intelligencematstikla tipa aizēnojums ground glass opacitySARS-CoV-2Covid-19Medicīnaplaušu bojājums lung damage
researchProduct